Transcat (TRNS) EBITDA Margin (2010 - 2025)

Transcat (TRNS) posted EBITDA Margin of 0.1% for Q4 2025, down 97.54% sequentially from 4.26% in Q3 2025, and down 304.0% YoY from 0.05% in Q4 2024.

Transcat (TRNS) EBITDA Margin (2010 - 2025) Analysis & Trends

Transcat has reported EBITDA Margin for 14 years, with the latest figure at 0.1% in Q4 2025.

Quarterly EBITDA Margin fell 304.0% year-over-year to 0.1% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 4.96% (down 62.0% YoY) and the FY2025 annual result came in at 6.42%, down 120.0% from the prior year.
EBITDA Margin eased to 0.1% in Q4 2025 per TRNS's latest filing, from 4.26% in the prior quarter.
Over five years, EBITDA Margin peaked at 15.0% in Q1 2023 and troughed at 0.1% in Q4 2025.
A 5-year average of 6.68% and a median of 6.79% in 2025 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2023 and 2024: EBITDA Margin soared 692 bps in 2023, then sank 528 bps in 2024.
Over 5 years, EBITDA Margin stood at 4.64% in 2021, then grew by 19 bps to 5.51% in 2022, then increased by 20 bps to 6.59% in 2023, then sank by 52 bps to 3.15% in 2024, then slumped by 97 bps to 0.1% in 2025.
According to Business Quant data, EBITDA Margin over the past three periods registered 0.1%, 4.26%, and 6.98% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Cintas	81.69 Bn	81.40 Bn	1.48 Bn	23.17%
2	Relx	64.97 Bn	64.80 Bn	-	-
3	Copart	32.09 Bn	28.74 Bn	732.88 Mn	37.53%
4	Global Payments	24.80 Bn	19.40 Bn	2.03 Bn	10.15%
5	Rb Global	16.24 Bn	15.72 Bn	935.50 Mn	17.07%
6	Aramark	15.68 Bn	15.18 Bn	430.34 Mn	4.26%
7	UL Solutions	15.20 Bn	14.77 Bn	417.00 Mn	18.38%
8	Rentokil Initial	11.80 Bn	9.27 Bn	-	-
9	Dolby Laboratories	6.05 Bn	5.38 Bn	264.68 Mn	11.25%
10	Transcat	855.75 Mn	850.81 Mn	-	-

Download Data